SCHEMBL532977

SCHEMBL532977

COc1ccc(-c2cccc(C)c2)c(C(=O)Nc2c(C)cc(C)c(N3CCCC3)c2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40
MAPT P10636 9/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 3/20 0.39
NPC1 O15118 2/20 0.39
QSOX1 O00391 1/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
CNR1 P21554 1/20 0.38
TSHR P16473 2/20 0.38
GFER P55789 1/20 0.38
USP2 O75604 1/20 0.38
HCRTR1 O43613 3/20 0.38
HCRTR2 O43614 3/20 0.38
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL532962 0.91 GAA (0.45) MAPTLMNASMN1; SMN2KDM4EGAA
SCHEMBL14288687 0.90 ALDH1A1 (0.42) MAPTALDH1A1LMNASMN1; SMN2KDM4E
SCHEMBL533536 0.87 L3MBTL1 (0.49) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL532940 0.83 GAA (0.50) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL533668 0.83 HDAC7 (0.43) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL533494 0.82 MAPT (0.55) MAPTNPC1RAB9AKDM4EGAA
SCHEMBL532826 0.79 ALDH1A1 (0.47) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL532809 0.78 ALDH1A1 (0.46) MAPTALDH1A1LMNANPC1RAB9A
SCHEMBL533977 0.78 GAA (0.57) MAPTALDH1A1RAB9AKDM4EGAA
SCHEMBL532941 0.77 MAPT (0.51) KCNK3KCNK9MAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415760-A2 CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2012-02-08 EP disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed
US-7319111-B2 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-01-15 US disclosed